1. 367TiPLUCY: A phase IIIb, real-world study of olaparib in HER2-negative metastatic breast cancer patients with a BRCA mutation. (23rd October 2018) Authors: Gelmon, K A; Walker, G P; Fisher, G V; McCutcheon, S C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial. (19th January 2018) Authors: Rugo, H S; Diéras, V; Gelmon, K A; Finn, R S; Slamon, D J; Martin, M; Neven, P; Shparyk, Y; Mori, A; Lu, D R; Bhattacharyya, H; Bartlett, C Huang; Iyer, S; Johnston, S; Ettl, J; Harbeck, N Journal: Annals of oncology Issue: Volume 29:Number 4(2018) Page Start: 888 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗